Global Circulating Tumor Cells Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Circulating Tumor Cells market size will reach 3,045.16 Million USD in 2025 and is projected to reach 12,512.23 Million USD by 2032, with a CAGR of 22.37% (2025-2032). Notably, the China Circulating Tumor Cells market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Circulating tumor cells (CTCs) are cancer cells that have detached from the primary tumor or metastatic sites and entered the bloodstream. These rare cells can circulate throughout the body and potentially play a role in the spread of cancer to other organs, a process known as metastasis. CTCs can be isolated from a blood sample, providing valuable information about the nature of a patient＇s cancer, its stage, and potential therapeutic targets. Analyzing CTCs has become an important area of cancer research, as it can aid in early cancer detection, monitoring disease progression, assessing treatment effectiveness, and identifying new strategies for personalized cancer therapy.
The major global suppliers of Circulating Tumor Cells include Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm, ApoCell, Greiner Bio-one, Advanced Cell Diagnostics, Aviva Biosciences, Fluxion Biosciences, Sysmex, Epic Sciences, Cynvenio, CytoTrack, Ikonisys, Vortex BioSciences, Gilupi, Biocept, ScreenCell, ANGLE, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Circulating Tumor Cells. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Circulating Tumor Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Circulating Tumor Cells Include:
Menarini-Silicon Biosystems
Qiagen（Adnagen）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Circulating Tumor Cells Product Segment Include:
CTC Enrichment
CTC Detection
CTC Analysis
Circulating Tumor Cells Product Application Include:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Circulating Tumor Cells Industry PESTEL Analysis
Chapter 3: Global Circulating Tumor Cells Industry Porter's Five Forces Analysis
Chapter 4: Global Circulating Tumor Cells Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Circulating Tumor Cells Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Circulating Tumor Cells Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Circulating Tumor Cells Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Circulating Tumor Cells market size will reach 3,045.16 Million USD in 2025 and is projected to reach 12,512.23 Million USD by 2032, with a CAGR of 22.37% (2025-2032). Notably, the China Circulating Tumor Cells market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Circulating tumor cells (CTCs) are cancer cells that have detached from the primary tumor or metastatic sites and entered the bloodstream. These rare cells can circulate throughout the body and potentially play a role in the spread of cancer to other organs, a process known as metastasis. CTCs can be isolated from a blood sample, providing valuable information about the nature of a patient＇s cancer, its stage, and potential therapeutic targets. Analyzing CTCs has become an important area of cancer research, as it can aid in early cancer detection, monitoring disease progression, assessing treatment effectiveness, and identifying new strategies for personalized cancer therapy.
The major global suppliers of Circulating Tumor Cells include Menarini-Silicon Biosystems, Qiagen（Adnagen）, Clearbridge Biomedics, Celsee, Fluidigm, ApoCell, Greiner Bio-one, Advanced Cell Diagnostics, Aviva Biosciences, Fluxion Biosciences, Sysmex, Epic Sciences, Cynvenio, CytoTrack, Ikonisys, Vortex BioSciences, Gilupi, Biocept, ScreenCell, ANGLE, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Circulating Tumor Cells. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Circulating Tumor Cells market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Circulating Tumor Cells Include:
Menarini-Silicon Biosystems
Qiagen（Adnagen）
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Circulating Tumor Cells Product Segment Include:
CTC Enrichment
CTC Detection
CTC Analysis
Circulating Tumor Cells Product Application Include:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Circulating Tumor Cells Industry PESTEL Analysis
Chapter 3: Global Circulating Tumor Cells Industry Porter's Five Forces Analysis
Chapter 4: Global Circulating Tumor Cells Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Circulating Tumor Cells Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Circulating Tumor Cells Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Circulating Tumor Cells Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Circulating Tumor Cells Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Circulating Tumor Cells Product by Type
- 1.2.1 CTC Enrichment
- 1.2.2 CTC Detection
- 1.2.3 CTC Analysis
- 1.3 Circulating Tumor Cells Product by Application
- 1.3.1 Breast Cancer
- 1.3.2 Prostate Cancer
- 1.3.3 Colorectal Cancer
- 1.3.4 Others
- 1.4 Global Circulating Tumor Cells Market Size Analysis (2020-2032)
- 1.5 Circulating Tumor Cells Market Development Status and Trends
- 1.5.1 Circulating Tumor Cells Industry Development Status Analysis
- 1.5.2 Circulating Tumor Cells Industry Development Trends Analysis
- 2 Circulating Tumor Cells Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Circulating Tumor Cells Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Circulating Tumor Cells Market Analysis by Country
- 4.1 Global Circulating Tumor Cells Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Circulating Tumor Cells Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Circulating Tumor Cells Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.5 China Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.6 France Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.14 India Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Circulating Tumor Cells Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Circulating Tumor Cells Market Revenue by Key Suppliers (2021-2025)
- 5.2 Circulating Tumor Cells Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Circulating Tumor Cells Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Circulating Tumor Cells Market Analysis by Type
- 6.1 Global Circulating Tumor Cells Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Circulating Tumor Cells Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Menarini-Silicon Biosystems
- 7.1.1 Menarini-Silicon Biosystems Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Portfolio
- 7.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Qiagen（Adnagen）
- 7.2.1 Qiagen（Adnagen） Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Qiagen（Adnagen） Circulating Tumor Cells Product Portfolio
- 7.2.3 Qiagen（Adnagen） Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Clearbridge Biomedics
- 7.3.1 Clearbridge Biomedics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Clearbridge Biomedics Circulating Tumor Cells Product Portfolio
- 7.3.3 Clearbridge Biomedics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Celsee
- 7.4.1 Celsee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Celsee Circulating Tumor Cells Product Portfolio
- 7.4.3 Celsee Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Fluidigm
- 7.5.1 Fluidigm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Fluidigm Circulating Tumor Cells Product Portfolio
- 7.5.3 Fluidigm Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 ApoCell
- 7.6.1 ApoCell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 ApoCell Circulating Tumor Cells Product Portfolio
- 7.6.3 ApoCell Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Greiner Bio-one
- 7.7.1 Greiner Bio-one Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Greiner Bio-one Circulating Tumor Cells Product Portfolio
- 7.7.3 Greiner Bio-one Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Advanced Cell Diagnostics
- 7.8.1 Advanced Cell Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Portfolio
- 7.8.3 Advanced Cell Diagnostics Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Aviva Biosciences
- 7.9.1 Aviva Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Aviva Biosciences Circulating Tumor Cells Product Portfolio
- 7.9.3 Aviva Biosciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Fluxion Biosciences
- 7.10.1 Fluxion Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Fluxion Biosciences Circulating Tumor Cells Product Portfolio
- 7.10.3 Fluxion Biosciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Sysmex
- 7.11.1 Sysmex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Sysmex Circulating Tumor Cells Product Portfolio
- 7.11.3 Sysmex Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Epic Sciences
- 7.12.1 Epic Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Epic Sciences Circulating Tumor Cells Product Portfolio
- 7.12.3 Epic Sciences Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Cynvenio
- 7.13.1 Cynvenio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Cynvenio Circulating Tumor Cells Product Portfolio
- 7.13.3 Cynvenio Circulating Tumor Cells Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 CytoTrack
- 7.14.1 Cyt
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
